期刊文献+

伊班膦酸钠在高龄老年骨质疏松症患者中的疗效与分析 被引量:1

下载PDF
导出
摘要 目的观察伊班膦酸钠在高龄老年骨质疏松症患者中的疗效和安全性。方法研究纳入高龄的骨质疏松症老年人56例。每3个月静滴伊班膦酸钠注射液2mg,同时口服钙尔奇D片1日1片,疗程为6个月。疗效指标为腰椎及髋部骨密度,血钙,血磷,血清碱性磷酸酶。安全性指标包括血、尿常规、肝肾功能、血电解质,心电图及不良反应。结果伊班膦酸钠治疗6个月后,腰椎1~4组BMD值有显著上升(腰椎P值〈0.001),股骨颈及全股骨BMD值增加不明显。血清碱性磷酸酶有所下降(P值〈0.05)。治疗前后患者血钙,血磷,肝肾功能均在正常范围内,身高,心电图无明显改变。伊班膦酸钠常见的不良反应是首次输液后低热,类流感样症状如肌肉酸痛,关节痛,疲乏不适等,大部分患者能耐受。结论伊班膦酸钠能有效增加高龄老年骨质疏松患者的椎体骨密度,不良反应少,患者耐受性好,药物依从性高,是安全,有效的高龄老年骨质疏松症患者的治疗方法。
出处 《海峡药学》 2012年第9期146-148,共3页 Strait Pharmaceutical Journal
  • 相关文献

参考文献13

  • 1原发性骨质疏松症诊治指南(2011年)[J].中华骨质疏松和骨矿盐疾病杂志,2011,4(1):2-17. 被引量:1833
  • 2Sambrook P. Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women [J]. Clin Interv Aging, 2007, 2 (1):65-72.
  • 3Harris ST, Blumentals WA, Miller PD. Ibandronate and the risk of non-vertebral and clinical fractures in women with postmenopausal os- teoporosis: results of a meta-analysis of phase III studies[J]. Curt Med Res Opin, 2008, 24 ( 1 ) : 237-245.
  • 4Frampton JE, Perry CM. Ibandronate: a review of its use in the man- agement of postmenopaused osteoporosis [J]. Drugs, 2008, 68 ( 18 ) : 2683-2707.
  • 5Stakkestad JA, Benevolenskaya LI, Stepan J J, et al. Intravenous iban- dronate injections given every three months: anew treatment option to prevent bone loss in postmenopausal women [JJ .Ann Rheum Dis, 2003, 62 (10) : 969-975.
  • 6Delmas PD, Adarni S, Strugala C, et al. Intravenous ibandronate injec- tions in postroenopausal women with osteoporosis: one-year results from the dosing intravenous administration study[J].Arthritis Rheum, 2006, 54(6) : 1838-1846.
  • 7Eisman JA, Civitelli R, Adami S, et al. Efficacy and tolerability of in- travenous ibandronate injections in postmenopausal osteoporosis: 2- year results from the DIVA study [J]. J Rheumatol, 2008, 35 (3): 488-497.
  • 8Recker RR, Ste-Marie LG, Langdahl B, et al. Effects of intermittent intravenous ibandronate injections on bone quality and micro-architec- ture in women with postmenopausal osteoporosis..the DIVA study [J]. Bone, 2010, 46(3) : 660-665.
  • 9Sebba AI, Emkey RD, Kohles JD, Sambrook PN. Ibandronate dose response is associated with increases in bone mineral density and re- ductions in elinieal fractures: results of a meta-analysis [J] . Bone, 2009, 44 ( 3 ) : 423 -427.
  • 10Li M, Xinqg XP, Zhang ZL, et al. Infusion of ibandronate once every 3 months effectively decreases bone resorption markers and increase bone mineral density in Chinese postmenopausal osteoporotic wom- en: a 1-year study[J]. J Bone Miner Metab, 2010, 28(3) :299-305.

共引文献1832

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部